Therefore, NRF1 maintains a 26S proteasome activity for normal development, whereas NRF3 alternatively maintains 20S proteasome activity for cancer development through both POMP-20S proteasome and CPEB3-NRF1 axes. The gene discussed is CPEB3; the disease is cancer.